HQL abrdn Life Sciences Investors
NYSE · SEC CIK 884121 · EDGAR
- Bought, last 12 months
- $144.2K 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 60 since 2021-08-12, latest 2026-07-20 14:36
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Pittard Christian | Dir | $133.7K | — |
| Mahai Chris LaVictoire | Dir | $10.5K | — |
Transactions 60
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-20 14:36 | 2026-07-16 | HQL | Mahai Chris LaVictoire | Dir | P - Purchase | $19.92 | +527 | 527 | New | +$10.5K | |
| 2025-12-18 | 2025-12-16 | HQL | Pittard Christian | Dir | P - Purchase | $16.88 | +7,923 | 7,923 | New | +$133.7K | |
| MI | 2025-09-23 | 2025-09-19+ | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $14.13 | -48.6K | 2.88M | -2% | -$687.1K |
| MI | 2025-09-19 | 2025-09-17+ | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $14.04 | -64.5K | 2.93M | -2% | -$906.1K |
| MI | 2025-09-17 | 2025-09-15+ | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $14.03 | -2,726 | 2.95M | -0.1% | -$38.2K |
| I | 2025-09-15 | 2025-09-11 | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $14.28 | -15.1K | 2.95M | -0.5% | -$215.9K |
| I | 2025-09-04 | 2025-09-02 | HQL | Weinstein Boaz | 10% | S - Sale | $14.04 | -14.1K | 2.97M | -0.5% | -$197.7K |
| I | 2025-09-02 | 2025-08-29 | HQL | Weinstein Boaz | 10% | S - Sale | $13.89 | -23.7K | 2.98M | -0.8% | -$329.5K |
| I | 2025-08-27 | 2025-08-26 | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $13.83 | -400 | 3.01M | -0.0% | -$5,532 |
| I | 2025-08-25 | 2025-08-21 | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $14.07 | -10.7K | 3.01M | -0.4% | -$150.7K |
| I | 2025-05-22 | 2025-05-20 | HQL | Weinstein Boaz | 10% | S - Sale | $12.71 | -11.4K | 3.02M | -0.4% | -$145.1K |
| I | 2025-05-19 | 2025-05-15 | HQL | Weinstein Boaz | 10% | S - Sale | $12.08 | -23.7K | 3.03M | -0.8% | -$286.6K |
| MI | 2025-05-15 | 2025-05-13+ | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $12.17 | -1,330 | 3.05M | -0.0% | -$16.2K |
| I | 2025-05-12 | 2025-05-08 | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $11.98 | -12.7K | 3.05M | -0.4% | -$152.0K |
| I | 2025-05-08 | 2025-05-07 | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $12.19 | -1,366 | 3.07M | -0.0% | -$16.7K |
| I | 2025-04-21 | 2025-04-17 | HQL | Weinstein Boaz | 10% | S - Sale | $11.78 | -9,144 | 3.07M | -0.3% | -$107.7K |
| I | 2025-04-17 | 2025-04-15 | HQL | Weinstein Boaz | 10% | S - Sale | $11.92 | -1,700 | 3.08M | -0.1% | -$20.3K |
| I | 2025-04-15 | 2025-04-14 | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $11.67 | -15.4K | 3.08M | -0.5% | -$179.7K |
| I | 2025-04-14 | 2025-04-10 | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $11.14 | -30.2K | 3.09M | -1.0% | -$335.9K |
| MI | 2025-04-07 | 2025-04-03+ | HQL | Weinstein Boaz | 10% | S - Sale | $11.97 | -17.2K | 3.12M | -0.5% | -$205.9K |
| MI | 2025-04-03 | 2025-04-01+ | HQL | Weinstein Boaz | 10% | S - Sale | $12.34 | -46.7K | 3.14M | -1% | -$576.8K |
| I | 2025-04-01 | 2025-03-31 | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $12.58 | -48.6K | 3.19M | -2% | -$611.7K |
| MI | 2025-03-31 | 2025-03-27+ | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $13.00 | -36.5K | 3.24M | -1% | -$475.0K |
| I | 2025-03-25 | 2025-03-24 | HQL | Weinstein Boaz | 10% | S - Sale | $13.21 | -2,329 | 3.27M | -0.1% | -$30.8K |
| I | 2025-02-27 | 2025-02-26 | HQL | Weinstein Boaz | 10% | S - Sale | $13.62 | -200 | 3.28M | -0.0% | -$2,724 |
| I | 2025-02-18 | 2025-02-13 | HQL | Weinstein Boaz | 10% | S - Sale | $13.88 | -100 | 3.28M | -0.0% | -$1,388 |
| I | 2025-02-13 | 2025-02-12 | HQL | Weinstein Boaz | 10% | S - Sale | $13.75 | -36.5K | 3.28M | -1% | -$502.4K |
| MI | 2025-02-12 | 2025-02-10+ | HQL | Saba Capital Management, L.P. | 10% | S - Sale | $13.89 | -62.7K | 3.31M | -2% | -$871.7K |
| MI | 2025-02-05 | 2025-02-03+ | HQL | Weinstein Boaz | 10% | S - Sale | $14.04 | -5,911 | 3.38M | -0.2% | -$83.0K |
| MI | 2025-02-03 | 2025-01-30+ | HQL | Weinstein Boaz | 10% | S - Sale | $14.21 | -37.0K | 3.40M | -1% | -$525.3K |
| I | 2025-01-30 | 2025-01-29 | HQL | Weinstein Boaz | 10% | S - Sale | $14.12 | -11.7K | 3.42M | -0.3% | -$164.8K |
| I | 2024-08-27 | 2024-08-23 | HQL | Maher Bill | Dir | P - Purchase | $15.37 | +650 | 1,715 | +61% | +$9,990 |
| 2024-07-18 | 2024-07-16 | HQL | DiMartino Rose | Dir | P - Purchase | $15.53 | +1,000 | 1,000 | New | +$15.5K | |
| I | 2024-06-27 | 2024-06-26 | HQL | Weinstein Boaz | 10% | P - Purchase | $14.07 | +100 | 3.43M | +0.0% | +$1,407 |
| I | 2024-06-25 | 2024-06-24 | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $14.08 | +13.8K | 3.43M | +0.4% | +$194.5K |
| MI | 2024-06-14 | 2024-06-12+ | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $13.83 | +10.9K | 3.41M | +0.3% | +$150.3K |
| MI | 2024-06-11 | 2024-06-10+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.72 | +11.7K | 3.40M | +0.3% | +$161.1K |
| MI | 2024-06-10 | 2024-06-06+ | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $13.78 | +13.4K | 3.39M | +0.4% | +$184.1K |
| MI | 2024-06-05 | 2024-06-04+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.61 | +59.4K | 3.38M | +2% | +$809.2K |
| I | 2024-06-03 | 2024-05-31 | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $13.29 | +21.4K | 3.32M | +0.6% | +$284.0K |
| MI | 2024-05-31 | 2024-05-28+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.14 | +47.4K | 3.26M | +1% | +$623.2K |
| I | 2024-05-23 | 2024-05-23 | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $13.50 | +1,303 | 3.25M | +0.0% | +$17.6K |
| I | 2024-05-17 | 2024-05-15 | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $14.19 | +34.8K | 3.25M | +1% | +$493.2K |
| I | 2024-05-14 | 2024-05-10 | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $13.86 | +57.9K | 3.22M | +2% | +$802.0K |
| MI | 2024-05-10 | 2024-05-08+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.76 | +28.4K | 3.16M | +0.9% | +$390.3K |
| MI | 2024-05-07 | 2024-05-06+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.74 | +60.9K | 3.08M | +2% | +$836.1K |
| MI | 2024-05-02 | 2024-05-01+ | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $13.46 | +26.5K | 3.07M | +0.9% | +$356.9K |
| I | 2024-05-01 | 2024-04-30 | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $13.13 | +16.6K | 3.04M | +0.5% | +$217.6K |
| I | 2024-04-29 | 2024-04-26 | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $13.00 | +120.3K | 3.03M | +4% | +$1.56M |
| MI | 2024-04-26 | 2024-04-24+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.01 | +118.1K | 2.81M | +4% | +$1.54M |
| MI | 2024-04-23 | 2024-04-22+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.14 | +50.2K | 2.74M | +2% | +$659.9K |
| MI | 2024-04-22 | 2024-04-18+ | HQL | Weinstein Boaz | 10% | P - Purchase | $12.81 | +124.2K | 2.74M | +5% | +$1.59M |
| 2024-04-12 | 2024-04-09 | HQL | Goetz Kathleen | Dir | P - Purchase | $13.32 | +400 | 1,085 | +58% | +$5,328 | |
| 2024-01-04 | 2024-01-02 | HQL | Reit Todd | Dir | P - Purchase | $13.80 | +1,000 | 1,000 | New | +$13.8K | |
| 2024-01-02 | 2023-12-28 | HQL | Maher Bill | Dir | P - Purchase | $13.57 | +1,000 | 1,000 | New | +$13.6K | |
| 2023-09-25 | 2023-09-25 | HQL | OMSTEAD DANIEL R | Pres, Dir | P - Purchase | $12.39 | +10.1K | 197.5K | +5% | +$125.1K | |
| 2023-09-20 | 2023-09-20 | HQL | OMSTEAD DANIEL R | Pres, Dir | P - Purchase | $12.68 | +12.0K | 187.4K | +7% | +$152.2K | |
| 2022-03-24 | 2022-03-23 | HQL | Goetz Kathleen | Dir | P - Purchase | $16.27 | +92.31 | 685.31 | +16% | +$1,502 | |
| 2022-01-27 | 2022-01-26 | HQL | Goetz Kathleen | Dir | P - Purchase | $17.54 | +593 | 593 | New | +$10.4K | |
| 2021-08-12 | 2021-08-11 | HQL | OMSTEAD DANIEL R | Pres, Dir | P - Purchase | $21.63 | +6,403 | 146.5K | +5% | +$138.5K |
Purchase Sale Sale after option exercise All abbreviations